IRWD Ironwood Pharmaceuticals, Inc.
$3.51▲ +0.29%
Healthcare
Other
After hours
$3.51▲ +0.00%
Oct 27, 4:01 PM ET
Volume 1.66M
Avg Volume (10D) 1.62M
Key Metrics & Fundamentals
Market Cap
$579.99M
P/E Ratio
4.6
Div Yield
0.00%
52W Range
1.47 - 5.78
% vs 50 MA
-12.22%
% vs 200 MA
-12.25%
RSI-14
39.7
MACD Histogram
+0.0000
Beta (1Y vs SPY)
1.86
Free Cash Flow
$58.28M
Gross Rev
$113.04M
Gross Profit
$113.04M
EBITDA
$81.39M
COGS
–
Operating Exp
$33.73M
Operating Income
$79.31M
EBIT
$79.31M
Pretax Income
$73.73M
Net Income
$51.29M
EPS (Diluted)
0.31
Price & Volume History
Loading chart…
Recent News
Ironwood Pharmaceuticals CEO Tom McCourt to Retire; Chief Commercial Officer Tammi Gaskins Named Successor
MT Newswires · Oct 16, 2026 7:55 AM ET
Ironwood Pharmaceuticals Appoints Tammi Gaskins as Chief Executive Officer
Business Wire · Oct 16, 2026 7:30 AM ET
Will Linzess Continue to Aid Ironwood's Top-Line Growth in Q3?
Zacks · Oct 7, 2026 9:57 AM ET
PGEN vs. IRWD: Which Biotech Stock Offers Better Growth Potential?
Zacks · Sep 30, 2026 11:08 AM ET
5 Small Drug Stocks Poised to Benefit From a Biotech Recovery
Zacks · Sep 14, 2026 9:30 AM ET
Ironwood Pharmaceuticals to Participate in the Wells Fargo 21st Annual Healthcare Conference
Business Wire · Sep 3, 2026 4:05 PM ET
Ironwood (IRWD) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 13, 2026 1:43 PM ET
Ironwood Q2 Earnings Beat Estimates, Revenues Lag, 2026 View Raised
Zacks · Aug 7, 2026 12:53 PM ET
Ironwood Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 7, 2026 8:30 AM ET
Ironwood Pharmaceuticals (IRWD) Is Up 14.2% After Raising 2026 Revenue Guidance – Has The Bull Case Changed?
Simply Wall St. · Aug 7, 2026 12:31 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See IRWD's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.